⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
POLYMED - Technical Analysis with Chart Patterns & Indicators
Last Updated Time : 20 Dec 25, 03:55 pm
Back to Technical ListTechnical Rating: 3.4
| Stock Code | POLYMED | Market Cap | 18,346 Cr. | Current Price | 1,810 ₹ | High / Low | 2,938 ₹ |
| Stock P/E | 52.6 | Book Value | 285 ₹ | Dividend Yield | 0.19 % | ROCE | 18.2 % |
| ROE | 14.2 % | Face Value | 5.00 ₹ | DMA 50 | 1,917 ₹ | DMA 200 | 2,061 ₹ |
| Chg in FII Hold | -1.64 % | Chg in DII Hold | 1.81 % | PAT Qtr | 89.0 Cr. | PAT Prev Qtr | 87.9 Cr. |
| RSI | 35.0 | MACD | -23.2 | Volume | 96,080 | Avg Vol 1Wk | 51,247 |
| Low price | 1,766 ₹ | High price | 2,938 ₹ | PEG Ratio | 1.70 | Debt to equity | 0.08 |
| 52w Index | 3.71 % | Qtr Profit Var | 2.10 % | EPS | 34.4 ₹ | Industry PE | 41.5 |
📊 Technical Analysis
- Chart Patterns: Stock is trading near strong support (1,766 ₹) with resistance around 1,917–2,061 ₹ (DMA levels).
- Moving Averages: Current price (1,810 ₹) is below both 50 DMA (1,917 ₹) and 200 DMA (2,061 ₹), indicating bearish bias.
- RSI: At 35.0, the stock is approaching oversold territory, suggesting potential rebound.
- MACD: Negative (-23.2), confirming weak momentum and bearish crossover.
- Bollinger Bands: Price is near lower band, signaling oversold condition and possible mean reversion.
- Volume Trends: Current volume (96,080) is higher than 1-week average (51,247), showing increased activity near support.
📈 Momentum & Signals
- Short-term Momentum: Weak, but oversold indicators suggest potential bounce from support.
- Entry Zone: 1,770–1,820 ₹ (near strong support).
- Exit Zone: 1,900–2,050 ₹ (resistance at DMA levels).
- Trend Status: Currently consolidating near support with bearish undertone.
✅ Positive
- ROCE (18.2%) and ROE (14.2%) show decent returns.
- EPS of 34.4 ₹ supports earnings visibility.
- DII holdings increased (+1.81%), showing domestic investor confidence.
- Debt-to-equity ratio of 0.08 indicates low leverage.
⚠️ Limitation
- Stock trading below both 50 DMA and 200 DMA.
- RSI and MACD show weak momentum.
- High P/E ratio (52.6) compared to industry PE (41.5), indicating premium valuation.
- Dividend yield is negligible (0.19%).
📉 Company Negative News
- FII holdings decreased (-1.64%), showing reduced foreign investor confidence.
- Stock has corrected sharply from 52-week high of 2,938 ₹.
📈 Company Positive News
- Quarterly PAT improved slightly from 87.9 Cr. to 89.0 Cr.
- DII holdings increased, showing domestic support.
- Strong fundamentals with moderate returns and low leverage.
🏭 Industry
- Industry PE is 41.5, lower than POLYMED’s PE of 52.6, highlighting premium valuation.
- Healthcare and medical devices sector growth supported by rising demand and innovation.
📝 Conclusion
- POLYMED is fundamentally stable but technically weak in the short term.
- Oversold indicators (RSI, Bollinger Bands) hint at possible rebound from support.
- Best strategy: Accumulate near 1,770–1,820 ₹ and book profits around 1,900–2,050 ₹.
- Overall trend: Consolidation with bearish bias, awaiting reversal signals.
NIFTY 50 - Today Top Technical Picks Stock Picks
NEXT 50 - Today Top Technical Picks Stock Picks
MIDCAP - Today Top Technical Picks Stock Picks
SMALLCAP - Today Top Technical Picks Stock Picks